Northwestern Medicine scientists take innovative cell-based approaches to induce immune tolerance In kidney transplant recipients.
The first annual Biomedical Data Science Day brought together biomedical informatics scientists and clinical informatics leaders from Feinberg and its health care affiliates.
Northwestern Medicine scientists and collaborators discovered that mutations in the TEK gene lead to primary congenital glaucoma, validating previous findings in mice and suggesting a target for future therapies.
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
Patients with psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab in three recent clinical trials led by a Northwestern Medicine investigator
Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
Northwestern Medicine scientists explore research that has shown how the balanced activities of two protein families regulate gene expression during embryonic development and how mutations that tip this balance lead to cancer.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
A new drug safely and effectively treats patients with ulcerative colitis, according to a recent study co-authored by Northwestern Medicine investigator Stephen Hanauer, MD.